Researchers suggest the 20% reduction in nonfatal heart attacks was the primary driver of this benefit for patients with type ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback